Need professional-grade analysis? Visit stockanalysis.com
$3.57B
19.61
20,221
2.69%
Price Chart
Risk-Adjusted Performance
Also Listed On
Fielmann Aktiengesellschaft (FIE) Price Performance
Fielmann Aktiengesellschaft (FIE) trades on XETRA (Frankfurt) in EUR. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at EUR42.95, down 0.35% from the previous close.
Over the past year, FIE has traded between a low of EUR39.17 and a high of EUR58.40. The stock has gained 1.2% over this period. It is currently 26.5% below its 52-week high.
Fielmann Aktiengesellschaft has a market capitalization of $3.57B, with a price-to-earnings ratio of 19.61 and a dividend yield of 2.69%.
About Fielmann Aktiengesellschaft
Fielmann Group AG engages in vision care and audiology business in Germany, Switzerland, Austria, Spain, North America, and internationally. The company manufactures and sells visual aids mainly glasses, eyewear frames and lenses, sunglasses, contact lenses, accessories, hearing systems and its accessories, as well as personal protective equipment. It offers its products under the fielmann, Optika Clarus, Optica & Audiologia Universitaria, Medical optica audicion, Shopko Optical, and SVS VISION brand names. The company sells its products through digital sales, retail stores, as well as Befitting, an optical e-commerce platform. The company was formerly known as Fielmann Aktiengesellschaft and changed its name to Fielmann Group AG in July 2023. Fielmann Group AG was founded in 1972 and is headquartered in Hamburg, Germany. Fielmann Group AG is a subsidiary of Korva SE.
Company Info
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Exchange
- XETRA (Frankfurt)
- Currency
- EUR
- Country
- Germany
Financial Metrics
- Revenue (TTM)
- $2.42B
- EBITDA
- $402.49M
- Profit Margin
- 7.55%
- EPS (TTM)
- 2.17
- Book Value
- 11.49
Technical Indicators
- 52 Week High
- €58.80
- 52 Week Low
- €37.50
- 50 Day MA
- €42.93
- 200 Day MA
- €48.75
- Beta
- 0.65
Valuation
- Trailing P/E
- 19.61
- Forward P/E
- 19.76
- Price/Sales
- 1.48
- Price/Book
- 3.73
- Enterprise Value
- $3.84B